hsa‐mir‐133a‐2 promotes the proliferation and invasion of cervical cancer cells by targeting the <scp>LAMB3</scp> ‐mediated <scp>PI3K</scp> / <scp>ATK</scp> pathway-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

hsa‐mir‐133a‐2 promotes the proliferation and invasion of cervical cancer cells by targeting the LAMB3 ‐mediated PI3K / ATK pathway

Published:2022-10-28 Issue:5 Volume:12 Page:5874-5888
ISSN:2045-7634
Container-title:Cancer Medicine
language:en
Short-container-title:Cancer Medicine

Author:

Sui Xiaoyu¹^ORCID,Sun Yurong²,Zhang Guiyu³,Chi Na¹,Guan Yitong¹,Wang Dan¹,Li Xiulan¹

Affiliation:

1. Department of Obstetrics and Gynecology The First Affiliated Hospital of Qiqihar Medical University Qiqihar P. R. China

2. Teaching and Research Section of Pathology Qiqihar Medical University Qiqihar P. R. China

3. Department of Obstetrics and Gynecology Qilu Hospital of Shandong University Shandong P. R. China

Funder

Department of Education, Heilongjiang Province

Publisher

Wiley

Subject

Cancer Research,Radiology, Nuclear Medicine and imaging,Oncology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1002/cam4.5380

Reference44 articles.

1. Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries

2. Immunotherapy and targeted therapy for cervical cancer: an update

3. Advances in diagnosis and treatment of metastatic cervical cancer

4. Cervical cancer in low and middle‑income countries (Review)

5. Review of the Standard and Advanced Screening, Staging Systems and Treatment Modalities for Cervical Cancer

Cited by 7 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. LAMB3: Central role and clinical significance in neoplastic and non-neoplastic diseases;Biomedicine & Pharmacotherapy;2024-09

2. CRABP2 promotes cell migration and invasion by activating PI3K/AKT and MAPK signalling pathways via upregulating LAMB3 in prostate cancer;The Journal of Biochemistry;2024-07-22

3. Laminin 332 expression levels predict clinical outcomes and chemotherapy response in patients with pancreatic adenocarcinoma;Frontiers in Cell and Developmental Biology;2023-09-15

4. Identification of a glycolysis-related miRNA Signature for Predicting Breast cancer Survival;Molecular Biotechnology;2023-08-03

5. Multi-omics analysis of LAMB3 as a potential immunological and biomarker in pan-cancer;Frontiers in Molecular Biosciences;2023-07-27

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3